Recombinant Anti-gp40 x Anti-TFRC Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-gp40 antibody are both extended with the scFv fragment from an anti-TFRC antibody. This BsAb can bind two tumor antigens simultaneously. It is designed for the research of Colon cancer; Ovarian cancer therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY